VasoSolutions successfully markets and supports an ever growing product line of innovative non-invasive technologies.
The continuing acceptance of Enhanced External Counterpulsation (EECP®) Therapy and the increased availability of EECP® Therapy Systems worldwide in hospitals, clinics and private physician practices have led to the treatment of over 300,000 patients worldwide. Complementing the EECP® product line, VasoSolutions also markets a complete line of BIOX™ ECG Holter and ambulatory blood pressure monitoring products, as well as the EZ™ patient management product line which includes pulse oximeters and a hand held ECG monitor.
VasoSolutions sales channels include a variety of direct and independent distributors and sales agencies around the world.
VasoSolutions is seeking International Partners! Click here for more information >